Full Spectrum™ Mushroom
Mycelium Products
Grifola frondosa
Description
Grifola
frondosa
MAITAKE
Maitake mushrooms have a long history as powerful medicinals dating back to the Han dynasty (206 BC to 220 AD) when they were used to treat stomach and spleen ailments, hemorrhoids, and nervous disorders. Studies started in the mid - 1980’s have shown that Maitake extracts protect against hepatitis, inhibit tumors, help regulate blood pressure, blood sugar, and cholesterol, and control obesity.
Maitake’s anti-tumor activity is quite potent, but like all of the medicinal mushrooms it is more effective with some tumors than with others. One study published in 1989 showed that one specific isolated Maitake extract was effective with allogenic and synergenic tumors, but did not inhibit the growth of leukemia. In another study, the results suggested that breast, lung, and liver cancers were improved by maitake, but it was less effective against bone and stomach cancers, or leukemia.”
Recently, reports have come from China indicating that a large daily dose of Maitake D-Fraction (3 grams/day), (as per Dr. Nanba's original formula designation; not necessarily the same thing as "D-Fraction™" available over the counter in the USA) combined with conventional treatments, has significantly increased the remission rates for lung cancer (82% remission with Maitake vs. 9.8% without).
Recognizing the benefits of Maitake, a trademarked brand of Maitake D-Fraction, called “Grifon®" -Pro D-Fraction® received FDA approval in 1998 to conduct a Phase II study on its effect on advanced breast and prostate cancer patients. (Note: the Maitake in Immune Fx is the D-Fraction extract as per Dr. Nanba's original research designation. It is not the "D-Fraction™" that is Trademarked in the United States).
It is significant that the FDA, recognizing the safety of this mushroom, allowed the sponsors to bypass the normally required Phase I studies which test for toxicity. If the Phase II study is successful, it should be followed by a series of Phase III studies and Maitake may be approved as a drug in this country in 10-15 years (probably at a much higher price). Until then, it will only be available as a nutritional supplement and not qualify for insurance reimbursement.
NOTE:
These claims have not been evaluated by the FDA. Our products
are not intended to diagnose, treat, cure or prevent any disease.
Health decisions are much too important to be made without the
advice of a Doctor or other Health Care Practitoner. We invite
and encourage you to share this information with your doctor.
We are happy to share all of our research materials with any
doctor who asks. |
1212 SW 5th Street
Grants Pass, OR 97526-2939
(541)
476-5588
(541) 476-1823 (FAX)
Pharmaceutical Mushrooms
is a division of
Northwest Botanicals, Inc,
an ingredient brokerage
located in
Grants Pass, Oregon, USA